Serpin Pharma

First in class, therapeutic peptides to mediate paradigm shift in disease management of inflammatory disorders such as Type I Diabetes.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Manassas, VA, USA
  • Currency USD
  • Founded December 2010
  • Employees 5
  • Website serpinpharma.com

Company Summary

Serpin Pharma, a biotech company with an experienced management team committed to commercialize first-in-class, anti-inflammatory/ immune modulatory peptides for treatment of inflammatory and autoimmune diseases. Our lead drug- SP16 is believed to provide a paradigm shift in disease management achieved by targeting critical pathways reducing inflammation, without the adverse general immunosuppression inflicted by other drugs.

Team

  • Cohava Gelber
    Founder & Exec. Chairperson

    >25 years of experience in biopharmaceutical development to phase III clinical trials (ImmuLogic Pharmaceutical Corp, Molecular Discoveries and MannKind Corp, ATCC). >$500MM of federal funding. > 70 patent filings; Ph.D. from the Weizmann Institute, MBA from Cornell U. and postdoc Stanford U.; Prof. at Duke University.

  • Guy Yachin
    President & CEO

    Engineer and MBA, President & CEO, serial entrepreneur and CEO of multiple biomedical companies; raised ~$100MM as CEO and Co-founder of Chiasma (announced a 600MM deal with Roche in February 2013) and MGVS (led it through a mega-deal with Teva Pharmaceuticals); has been an active board of several successful private and public companies, among them Orgenesis (ORGS), Enzymotec, Remon Medical (acquired by BSC) and NanoPass.

  • Soren Mogelsvang
    Founder & Vice President of R&D

    Dr. Mogelsvang has over 10 years of experience in discovery and translational research, in the areas of diabetes and cancer. He holds a Ph.D. degree from the University of Cambridge, England.

  • Cohava Gelber

Advisors

  • Nixon Peabody
    Lawyer
    Unconfirmed
    Weyrich, Cronin & Sorra
    Accountant
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free